FDA says PTC's marketing application insufficient

(Reuters) - The U.S. Food and Drug Administration said PTC Therapeutics Inc's marketing application for its muscle disorder drug was not sufficient to merit review.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro